Last reviewed · How we verify

NCT07323550

Single-Dual Task Performance in Children With Autism Spectrum Disorder and Typically Developing Children

Completed Last updated 6 February 2026
What this trial tests

trial testing Single- and Dual-Task Condition Assessment in Autism in 90 participants. Completed in 5 February 2026.

Timeline
1 September 2025
Primary endpoint
1 October 2025
5 February 2026

Quick facts

Lead sponsorAtlas University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment90
Start date1 September 2025
Primary completion1 October 2025
Estimated completion5 February 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Atlas University

Who can join

Adults 5 to 16, any sex, with Autism or Dual Task. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare the effects of single-task and dual-task conditions on motor performance and postural control in children with Autism Spectrum Disorder (ASD) and typically developing children. Participants' performance under single-task and dual-task conditions involving cognitive load will be evaluated to examine how cognitive demands affect physical task performance in both groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Autism

Currently open trials in the same condition.

Other Atlas University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07323550.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing